Access

Letters to Nature

Nature 433, 523-527 (3 February 2005) | doi:10.1038/nature03253; Received 1 November 2004; Accepted 3 December 2004

Open Innovation Challenges

naturejobs

CD36 is a sensor of diacylglycerides

Kasper Hoebe1, Philippe Georgel1, Sophie Rutschmann1, Xin Du1, Suzanne Mudd1, Karine Crozat1, Sosathya Sovath1, Louis Shamel1, Thomas Hartung2, Ulrich Zähringer3 & Bruce Beutler1

  1. Department of Immunology, The Scripps Research Institute, La Jolla, California 92037, USA
  2. EU Joint Research Centre, ECVAM, I-21020 Ispra, Italy
  3. Research Center Borstel, Leibniz-Center for Medicine and Biosciences, 23845 Borstel, Germany

Correspondence to: Bruce Beutler1 Correspondence and requests for materials should be addressed to B.B. (Email: bruce@scripps.edu).

Top

Toll-like receptor 2 (TLR2) is required for the recognition of numerous molecular components of bacteria1, 2, 3, 4, 5, 6, 7, 8, fungi9, 10 and protozoa11. The breadth of the ligand repertoire seems unusual, even if one considers that TLR2 may form heteromers with TLRs 1 and 6 (ref. 12), and it is likely that additional proteins serve as adapters for TLR2 activation. Here we show that an N-ethyl-N-nitrosourea-induced nonsense mutation of Cd36 (oblivious) causes a recessive immunodeficiency phenotype in which macrophages are insensitive to the R-enantiomer of MALP-2 (a diacylated bacterial lipopeptide) and to lipoteichoic acid. Homozygous mice are hypersusceptible to Staphylococcus aureus infection. Cd36obl macrophages readily detect S-MALP-2, PAM2CSK4, PAM3CSK4 and zymosan, revealing that some—but not all—TLR2 ligands are dependent on CD36. Already known as a receptor for endogenous molecules, CD36 is also a selective and nonredundant sensor of microbial diacylglycerides that signal via the TLR2/6 heterodimer.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Research Highlights

Nature Immunology News and Views (01 Mar 2005)

Extolling the diversity of bacterial endotoxins

Nature Immunology News and Views (01 Apr 2001)